Statistics for A Phase 2b randomised, controlled, partially blinded trial of the HIV Nucleoside Reverse Transcriptase Inhibitor BMS-986001 (AI467003): Weeks 24 and 48 Efficacy, Safety, Bone and Metabolic Results
Total visits
| views | |
|---|---|
| A Phase 2b randomised, controlled, partially blinded trial of the HIV Nucleoside Reverse Transcriptase Inhibitor BMS-986001 (AI467003): Weeks 24 and 48 Efficacy, Safety, Bone and Metabolic Results | 299 |
Total visits per month
| views | |
|---|---|
| December 2023 | 0 |
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
File Visits
| views | |
|---|---|
| Gupta_2016_phase-2b.pdf | 530 |
Top country views
| views | |
|---|---|
| United States | 185 |
| Germany | 15 |
| South Korea | 15 |
| Poland | 6 |
| Sweden | 6 |
| Ukraine | 6 |
| United Kingdom | 4 |
| Russia | 4 |
| Canada | 3 |
| China | 2 |
| Spain | 1 |
| France | 1 |
| Greece | 1 |
| Italy | 1 |
| Malaysia | 1 |
| Peru | 1 |
| Thailand | 1 |
| Turkey | 1 |
| South Africa | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 58 |
| Ann Arbor | 23 |
| Fairfield | 18 |
| Kiez | 12 |
| Houston | 11 |
| White Plains | 8 |
| Jacksonville | 7 |
| Seoul | 7 |
| Washington | 7 |
| Kiev | 6 |
| Kraków | 6 |
| Baltimore | 5 |
| Stockholm | 5 |
| London | 3 |
| Saint Petersburg | 3 |
| San Francisco | 3 |
| Cambridge | 2 |
| Dearborn | 2 |
| Grafenau | 2 |
| Revere | 2 |
| Toronto | 2 |
| Alexandria | 1 |
| Ashburn | 1 |
| Bangkok | 1 |
| Beijing | 1 |
| Binghamton | 1 |
| Fort Washington | 1 |
| Grado | 1 |
| Gunzenhausen | 1 |
| Indianapolis | 1 |
| Istanbul | 1 |
| Kuala Lumpur | 1 |
| La Jolla | 1 |
| Lake Mary | 1 |
| Lima | 1 |
| Malmö | 1 |
| Milan | 1 |
| Moscow | 1 |
| New York | 1 |
| Paralía | 1 |
| Philadelphia | 1 |
| Princeton | 1 |
| Roubaix | 1 |
| Scottsdale | 1 |
| Shenzhen | 1 |
| Tustin | 1 |